Imaging of metabolic bone diseases

被引:18
|
作者
Haugeberg, Glenn [1 ,2 ]
机构
[1] Norwegian Univ Sci & Technol, MTFS, Dept Neurosci, Div Rheumatol, N-7489 Trondheim, Norway
[2] Sorlandet Hosp, Dept Rheumatol, N-4604 Kristiansand, Norway
来源
关键词
metabolic bone diseases; osteoporosis; Paget's disease; osteomalacia; imaging; DEXA; DXR; ultrasonography; MRI; CT; bone scintigraphy;
D O I
10.1016/j.berh.2008.09.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bone scintigraphy and X-ray are complementary in the assessment of Paget's disease. Whereas bone scintigraphy allows visualization of the whole skeleton and 'hot spots', X-ray enables visualization of more detailed images of the pagetic bone lesion. X-ray may be invaluable in the diagnosis of osteomalacia, especially in children. As osteomalacia is characterized by impaired bone mineralization, the use of bone density measures may lead to misinterpretation of the condition as osteoporosis. Dual-energy X-ray absorptiometry at the femoral neck is the 'gold standard' for the assessment of osteoporosis. However, all devices are useful to predict the risk of fracture. In the future, high-resolution computer tomography and magnetic resonance imaging may become valuable clinical tools, capturing the architectural aspect of bone strength and improving fracture prediction models.
引用
收藏
页码:1127 / 1139
页数:13
相关论文
共 50 条
  • [21] Bone marrow transplantation for metabolic diseases
    Parkman, R
    Crooks, G
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 1996, 16 (02) : 429 - &
  • [22] Metabolic bone diseases in intestinal failure
    Allan, P. J.
    Lal, S.
    JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2020, 33 (03) : 423 - 430
  • [23] METABOLIC DISEASES OF BONE - KINETIC STUDIES
    RAY, RD
    MUELLER, KH
    SANKARAN, B
    MENSEN, ED
    SCHWARTZ, TB
    MEDICAL CLINICS OF NORTH AMERICA, 1965, 49 (01) : 241 - &
  • [24] Metabolic bone disease in gut diseases
    Lipkin, EW
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1998, 27 (02) : 513 - +
  • [25] Genetic approaches to metabolic bone diseases
    Hannan, Fadil M.
    Newey, Paul J.
    Whyte, Michael P.
    Thakker, Rajesh V.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (06) : 1147 - 1160
  • [26] Bisphosphonates in the treatment of metabolic bone diseases
    Arantes, Henrique Pierotti
    da Silva, Andre Goncalves
    Lazaretti-Castro, Marise
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (02) : 206 - 212
  • [27] Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases
    Oton-Gonzalez, Lucia
    Mazziotta, Chiara
    Iaquinta, Maria Rosa
    Mazzoni, Elisa
    Nocini, Riccardo
    Trevisiol, Lorenzo
    D'Agostino, Antonio
    Tognon, Mauro
    Rotondo, John Charles
    Martini, Fernanda
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [28] Growth factors, bone metabolism, and metabolic bone diseases
    Canalis, E
    ENDOCRINOLOGIST, 1996, 6 (02): : 89 - 94
  • [29] METABOLIC BONE DISEASES ASSOCIATED WITH MALIGNANCY
    GORDAN, GS
    LICHTENSTEIN, L
    ROOF, BS
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1971, 7 (03): : 499 - +
  • [30] Drugs for the treatment of metabolic bone diseases
    Drake, Matthew T.
    Cremers, Serge
    Russell, R. Graham
    Bilezikian, John P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (06) : 1049 - 1051